| Identification | Back Directory | [Name]
troponin I type 3 (cardiac) | [CAS]
339163-65-4 | [Synonyms]
CMH7
RCM1
cTnI
CMD2A
CMD1FF
RCM 1 NEW
Troponin I ELISA Kit
troponin I type 3 (cardiac)
Anti-TNNI3 antibody produced in goat
Monoclonal Anti-TNNI3 antibody produced in mouse
3-Pyridinecarbonitrile, 2-[[2-oxo-2-(2-thienyl)ethyl]thio]-4,6-di-2-thienyl- | [Molecular Formula]
C20H12N2OS4 | [MDL Number]
MFCD00742440 | [MOL File]
339163-65-4.mol | [Molecular Weight]
424.58 |
| Chemical Properties | Back Directory | [Boiling point ]
632.8±55.0 °C(Predicted) | [density ]
1.49±0.1 g/cm3(Predicted) | [storage temp. ]
Keep in dark place,Inert atmosphere,Room temperature | [solubility ]
DMSO : 16.67 mg/mL (39.26 mM) | [form ]
buffered aqueous solution | [pka]
-1.42±0.37(Predicted) | [color ]
Off-white to gray | [biological source]
mouse |
| Hazard Information | Back Directory | [General Description]
Troponin I3, cardiac type (TNNI3), also known as cardiac troponin I (cTnI), is the inhibitory element of troponin. It possesses an inhibitory peptide (IP) domain and a switch peptide (SP) domain that is located N-terminal of the IP domain. The gene encoding TNNI3 is localized on human chromosome 19q13.42. | [Biochem/physiol Actions]
Troponin I3, cardiac type (TNNI3) or cardiac troponin I (cTnI) modulates the diastolic function of the heart. Low expression of TNNI3 is associated with cardiac diastolic dysfunction. Elevated expression of the protein indicates cardiac injury. TNNI3 is a biomarker for myocardial infarction and mutations in the gene encoding it have been linked to hypertrophic cardiomyopathy. | [storage]
Store at -20°C |
|
|